GNC 10-Q 29 Jul 14 2014 Q2 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	6 Months Ended
	Jun. 30, 2014	Jul. 25, 2014
Document and Entity Information	'	'
Entity Registrant Name	'GNC HOLDINGS, INC.	'
Entity Central Index Key	'0001502034	'
Document Type	'10-Q	'
Document Period End Date	30-Jun-14	'
Amendment Flag	'false	'
Current Fiscal Year End Date	'--12-31	'
Entity Current Reporting Status	'Yes	'
Entity Filer Category	'Large Accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	89,984,798
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q2	'

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Current assets:	'	'
Cash and cash equivalents	$118,545	$226,217
Receivables, net	142,864	144,833
Inventories (Note 3)	588,375	547,916
Prepaids and other current assets	43,733	47,081
Total current assets	893,517	966,047
Long-term assets:	'	'
Goodwill (Note 4)	674,800	666,346
Brands (Note 4)	720,000	720,000
Other intangible assets, net (Note 4)	138,948	142,774
Property, plant and equipment, net	220,947	206,754
Other long-term assets	38,736	38,426
Total long-term assets	1,793,431	1,774,300
Total assets	2,686,948	2,740,347
Current liabilities:	'	'
Accounts payable	148,958	135,164
Current portion, long-term debt (Note 5)	4,825	5,443
Deferred revenue and other current liabilities	107,499	106,459
Total current liabilities	261,282	247,066
Long-term liabilities:	'	'
Long-term debt (Note 5)	1,339,613	1,341,656
Deferred tax liabilities, net	283,325	282,377
Other long-term liabilities	59,358	53,669
Total long-term liabilities	1,682,296	1,677,702
Total liabilities	1,943,578	1,924,768
Commitments and Contingencies (Note 7)	'	'
Common stock, $0.001 par value, 300,000 shares authorized:	'	'
Class A, 113,090 shares issued and 89,885 shares outstanding and 23,205 shares held in treasury at June 30, 2014 and 112,961 shares issued and 93,989 shares outstanding and 18,972 shares held in treasury at December 31, 2013	113	112
Paid-in-capital	854,330	847,886
Retained earnings	810,790	700,108
Treasury stock, at cost	-924,635	-734,482
Accumulated other comprehensive income	2,772	1,955
Total stockholders’ equity	743,370	815,579
Total liabilities and stockholders’ equity	$2,686,948	$2,740,347

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Thousands, except Per Share data, unless otherwise specified
Common stock, par value (in dollars per share)	$0.00	$0.00
Common stock, shares authorized	300,000	300,000
Class A Common Stock	'	'
Common stock, shares issued	113,069	112,961
Common stock, shares outstanding	89,885	93,989
Common stock, shares held in treasury	23,184	18,972

Consolidated_Statements_of_Inc

Consolidated Statements of Income (USD $)	3 Months Ended		6 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Income Statement [Abstract]	'	'	'	'
Revenue	$675,216	$676,276	$1,352,492	$1,340,966
distribution and occupancy	416,636	420,384	837,920	828,937
Gross profit	258,580	255,892	514,572	512,029
Compensation and related benefits	81,159	81,104	163,564	160,649
Advertising and promotion	22,205	16,282	39,090	36,722
Other selling, general and administrative	37,480	34,917	72,793	66,582
Other (income) expense, net	-3,315	-82	-3,181	-115
Operating income	121,051	123,671	242,306	248,191
Interest expense, net (Note 5)	11,675	11,101	23,206	22,116
Income before income taxes	109,376	112,570	219,100	226,075
Income tax expense (Note 10)	39,489	40,882	79,310	81,744
Net income	$69,887	$71,688	$139,790	$144,331
Earnings per share:	'	'	'	'
Basic (in dollars per share)	$0.77	$0.74	$1.52	$1.47
Diluted (in dollars per share)	$0.77	$0.73	$1.52	$1.46
Weighted average common shares outstanding:	'	'	'	'
Basic (in shares)	90,414	97,428	91,687	98,208
Diluted (in shares)	90,931	98,333	92,265	99,106
Dividends declared per share: (in dollars per share)	$0.16	$0.15	$0.32	$0.30

Consolidated_Statements_of_Com

Consolidated Statements of Comprehensive Income (USD $)	3 Months Ended		6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Statement of Comprehensive Income [Abstract]	'	'	'	'
Net income	$69,887	$71,688	$139,790	$144,331
Other comprehensive income (loss):	'	'	'	'
Foreign currency translation adjustments	1,598	-708	817	-1,305
Comprehensive income	$71,485	$70,980	$140,607	$143,026

Consolidated_Statements_of_Sto

Consolidated Statements of Stockholders' Equity (USD $)	Total	Treasury Stock	Paid-in-Capital	Retained Earnings	Accumulated Other Comprehensive Income/(Loss)	Class A Common Stock	Class A Common Stock
In Thousands, unless otherwise specified	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)		Common Stock
							USD ($)
Balance (in usd) at Dec. 31, 2012	$882,039	($423,900)	$810,094	$492,687	$3,047	'	$111
Balance (in shares) at Dec. 31, 2012	'	'	'	'	'	'	99,244
Increase (Decrease) in Stockholders' Equity	'	'	'	'	'	'	'
Comprehensive income	143,026	'	'	144,331	-1,305	'	'
Repurchase of treasury stock (in shares)	'	'	'	'	'	'	-4,180
Repurchase of treasury stock	-181,310	-181,310	'	'	'	'	'
Common stock dividends	-29,140	'	'	-29,140	'	'	'
Conversions to common stock (in shares)	'	'	'	'	'	'	614
Conversions to common stock	12,568	'	12,567	'	'	'	1
Non-cash stock-based compensation	3,874	'	3,874	'	'	'	'
Balance (in usd) at Jun. 30, 2013	831,057	-605,210	826,535	607,878	1,742	'	112
Balance (in shares) at Jun. 30, 2013	'	'	'	'	'	'	95,678
Balance (in usd) at Dec. 31, 2013	815,579	-734,482	847,886	700,108	1,955	'	112
Balance (in shares) at Dec. 31, 2013	'	'	'	'	'	93,989	93,989
Increase (Decrease) in Stockholders' Equity	'	'	'	'	'	'	'
Comprehensive income	140,607	'	'	139,790	817	'	'
Repurchase of treasury stock (in shares)	'	'	'	'	'	'	-4,233
Repurchase of treasury stock	-190,153	-190,153	'	'	'	'	'
Common stock dividends	-29,108	'	'	-29,108	'	'	'
Conversions to common stock (in shares)	'	'	'	'	'	'	129
Conversions to common stock	3,094	'	3,093	'	'	'	1
Non-cash stock-based compensation	3,351	'	3,351	'	'	'	'
Balance (in usd) at Jun. 30, 2014	$743,370	($924,635)	$854,330	$810,790	$2,772	'	$113
Balance (in shares) at Jun. 30, 2014	'	'	'	'	'	89,885	89,885

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013
CASH FLOWS FROM OPERATING ACTIVITIES:	'	'
Net income	$139,790	$144,331
Adjustments to reconcile net income to net cash provided by operating activities:	'	'
Depreciation and amortization expense	27,401	25,131
Amortization of debt costs	895	1,258
Increase in provision for inventory losses	10,395	8,990
Decrease (increase) in receivables	892	-13,948
Increase in inventory	-48,990	-61,874
Decrease (increase) in prepaids and other current assets	3,512	-1,997
Increase in accounts payable	12,348	32,449
Decrease in deferred revenue and other current liabilities	-303	-13,250
Other operating activities	7,387	5,742
Net cash provided by operating activities	153,327	126,832
CASH FLOWS FROM INVESTING ACTIVITIES:	'	'
Capital expenditures	-36,100	-21,475
Cash paid for acquisitions, net of cash acquired	-6,402	0
Other investing activities	-284	-1,194
Net cash used in investing activities	-42,786	-22,669
CASH FLOWS FROM FINANCING ACTIVITIES:	'	'
Dividends paid and declared to shareholders	-28,960	-29,078
Payments on long-term debt	-3,040	-1,893
Proceeds from exercised stock options	1,908	6,280
Tax benefit from exercise of stock options	1,681	6,970
Repurchase of treasury stock	-190,153	-181,310
Net cash used in financing activities	-218,564	-199,031
Effect of exchange rate on cash and cash equivalents	351	352
Net decrease in cash and cash equivalents	-107,672	-94,516
Beginning balance, cash and cash equivalents	226,217	158,541
Ending balance, cash and cash equivalents	$118,545	$64,025

NATURE_OF_BUSINESS

NATURE OF BUSINESS	6 Months Ended
	Jun. 30, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
NATURE OF BUSINESS	'
	NATURE OF BUSINESS
	General Nature of Business. GNC Holdings, Inc., a Delaware corporation (“Holdings,” and collectively with its subsidiaries and, unless the context requires otherwise, its and their respective predecessors, the “Company”), is a global specialty retailer of health and wellness products, which include: vitamins, minerals and herbal supplements, sports nutrition products, diet products and other wellness products.
	The Company is vertically integrated, as its operations consist of purchasing raw materials, formulating and manufacturing products and selling the finished products through its three segments: Retail, Franchising and Manufacturing/Wholesale. Corporate retail store operations are located in the United States, Canada, Puerto Rico and beginning in 2014, Ireland with the acquisition of THSD d/b/a The Health Store ("The Health Store"). In addition, the Company offers products domestically through GNC.com, LuckyVitamin Corp. ("Lucky Vitamin"), www.drugstore.com, and beginning in 2013, the United Kingdom with the acquisition of Discount Supplements, Ltd. (“Discount Supplements”). Franchise stores are located in the United States and over 50 international countries (including distribution centers where retail sales are made). The Company operates its primary manufacturing facilities in South Carolina and distribution centers in Arizona, Pennsylvania and South Carolina. The Company manufactures the majority of its branded products, but also merchandises various third-party products. Additionally, the Company licenses the use of its trademarks and trade names.
	The processing, formulation, packaging, labeling and advertising of the Company’s products are subject to regulation by various federal agencies, including the Food and Drug Administration (the “FDA”), the Federal Trade Commission, the Consumer Product Safety Commission, the United States Department of Agriculture and the Environmental Protection Agency. These activities are also regulated by various agencies of the states and localities in which the Company’s products are sold.
	Recent Significant Transactions. In November 2013, the board of directors of Holdings approved a multi-year program to repurchase up to an aggregate of $500.0 million of Holdings' common stock. We repurchased $190.2 million of common stock during the six months ended June 30, 2014 and have utilized $249.3 million of the program.
	In October 2013, the Company acquired Discount Supplements, an online retailer of multi-brand sports nutrition products in the United Kingdom. The aggregate purchase price of Discount Supplements was $33.3 million.
	On April 17, 2014, the Company acquired The Health Store, a nine store chain based in Dublin, Ireland. The aggregate purchase price of The Health Store was $8.9 million.

BASIS_OF_PRESENTATION_AND_SUMM

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended
	Jun. 30, 2014
Accounting Policies [Abstract]	'
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	'
	BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	The accompanying unaudited consolidated financial statements have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission. The year-end consolidated balance sheet was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America (“U.S. GAAP”). These interim consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the Company’s audited financial statements in Holdings’ Annual Report on Form 10-K filed for the year ended December 31, 2013. There have been no material changes to the application of significant accounting policies and significant judgments and estimates since December 31, 2013.
	The accompanying unaudited consolidated financial statements include all adjustments (consisting of a normal and recurring nature) that management considers necessary for a fair statement of financial information for the interim periods. Interim results are not necessarily indicative of the results that may be expected for the remainder of the year ending December 31, 2014.
	Principles of Consolidation. The consolidated financial statements include the accounts of Holdings and all of its subsidiaries. All material intercompany transactions have been eliminated in consolidation.
	The Company has no relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off balance sheet arrangements or other contractually narrow or limited purposes.
	Use of Estimates.  The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions. Accordingly, these estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. Some of the most significant estimates pertaining to the Company include the valuation of inventories, the allowance for doubtful accounts and income taxes. On a regular basis, management reviews its estimates utilizing currently available information, changes in facts and circumstances, historical experience and reasonable assumptions. After such reviews and if deemed appropriate, those estimates are adjusted accordingly. Actual results could differ from those estimates.
	Recent Accounting Pronouncements
	In July 2013, the Financial Accounting Standards Board ("FASB") issued accounting standard ASU 2013-11, regarding the presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. This standard requires entities to present an unrecognized tax benefit as a reduction of a deferred tax asset for a net operating loss (“NOL”) or tax credit carryforward whenever the NOL or tax credit carryforward would be available to reduce the additional taxable income or tax due if the tax position is disallowed. This accounting standard update requires entities to assess whether to net the unrecognized tax benefit with a deferred tax asset as of the reporting date. This guidance is effective for fiscal years beginning after December 15, 2013, with early adoption permitted. The Company adopted this guidance during the first quarter of 2014. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements.
	In May 2014, the FASB issued accounting standard ASU 2014-09, which updates revenue recognition guidance relating to contracts with customers. This standard states that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This standard is effective for fiscal years beginning after December 15, 2016. The Company is currently evaluating the impact this guidance will have on the consolidated financial statements.
	In June 2014, the FASB issued accounting standard ASU 2014-12, which updates guidance on performance stock awards. The update states that for any award that has a performance target that affects vesting and that could be achieved after the requisite period, that performance target should still be treated as a performance condition. This standard is effective for fiscal years beginning after December 15, 2015. The Company is currently evaluating the impact this guidance will have on the consolidated financial statements.

INVENTORIES

INVENTORIES	6 Months Ended
	Jun. 30, 2014
Inventory Disclosure [Abstract]	'
INVENTORIES	'
	INVENTORIES
	The net carrying value of inventories consisted of the following:
		30-Jun-14		31-Dec-13
		(unaudited)
		(in thousands)
	Finished product ready for sale	$	503,280	$	458,366
	Work-in-process, bulk product and raw materials	77,050		81,575
	Packaging supplies	8,045		7,975
	Total	$	588,375	$	547,916

GOODWILL_AND_INTANGIBLE_ASSETS

GOODWILL AND INTANGIBLE ASSETS, NET	6 Months Ended
	Jun. 30, 2014
Goodwill and Intangible Assets Disclosure [Abstract]	'
GOODWILL AND INTANGIBLE ASSETS, NET	'
	GOODWILL AND INTANGIBLE ASSETS, NET
	For the six months ended June 30, 2014 and 2013, the Company acquired 17 and 11 franchise stores, respectively. These acquisitions were accounted for using the acquisition method of accounting and the Company recorded the acquired inventory, fixed assets, franchise rights and goodwill, with an applicable reduction to receivables and cash. The total purchase price associated with these acquisitions was $2.2 million and $2.0 million, respectively, of which $1.4 million and $1.2 million, respectively, was paid in cash.
	On April 17, 2014, the Company acquired the assets and assumed the liabilities of The Health Store, which was accounted for as a business combination. The total purchase price for this acquisition was approximately $8.9 million. Of the purchase price, $6.9 million was allocated to goodwill, $0.8 million to amortizable intangibles, and $0.3 million to working capital.
	The following table summarizes the Company’s goodwill activity:
		Retail				Franchising			Manufacturing/				Total
									Wholesale
		(in thousands)
	Balance at December 31, 2013	346,202				$	117,303		$	202,841			$	666,346
	Acquired franchise stores	860				—			—				860
	Acquisition of The Health Store	6,853				—			—				6,853
	Translation effect of exchange rates	741				—			—				741
	Balance at June 30, 2014 (unaudited)	$	354,656			$	117,303		$	202,841			$	674,800
	Intangible assets other than goodwill consisted of the following:
		Retail				Franchise			Operating				Other				Total
		Brand				Brand			Agreements				Intangibles
		(in thousands)
	Balance at December 31, 2013	$	500,000			$	220,000		$	125,665			$	17,109			$	862,774
	Acquired franchise stores	—				—			—				515				515
	Acquisition of The Health Store	—				—			—				788				788
	Amortization expense	—				—			(3,326		)		(2,072		)		(5,398		)
	Translation effect of exchange rates	—				—			—				269				269
	Balance at June 30, 2014 (unaudited)	$	500,000			$	220,000		$	122,339			$	16,609			$	858,948
	The following table reflects the gross carrying amount and accumulated amortization for each major intangible asset:
		Weighted-			June 30, 2014											December 31, 2013
		Average
		Life			Cost			Accumulated				Carrying				Cost				Accumulated			Carrying
								Amortization				Amount								Amortization			Amount
					(unaudited)
					(in thousands)
	Brands - retail	—			$	500,000		$	—			$	500,000			$	500,000			$	—		$	500,000
	Brands - franchise	—			220,000			—				220,000				220,000				—			220,000
	Retail agreements	30.3			31,000			(7,828		)		23,172				31,000				(7,301		)	23,699
	Franchise agreements	25			70,000			(20,417		)		49,583				70,000				(19,017		)	50,983
	Manufacturing agreements	25			70,000			(20,417		)		49,583				70,000				(19,017		)	50,983
	Other intangibles	8.1			21,429			(5,855		)		15,574				20,327				(3,995		)	16,332
	Franchise rights	3			5,978			(4,942		)		1,036				5,463				(4,686		)	777
	Total	23.4			$	918,407		$	(59,459	)		$	858,948			$	916,790			$	(54,016	)	$	862,774
	The following table represents future estimated amortization expense of intangible assets with finite lives at June 30, 2014:
		Years ending December 31,		Estimated
				amortization
				expense
				(unaudited)
				(in thousands)
		2014		$	5,483
		2015		10,756
		2016		9,870
		2017		7,784
		2018		7,700
		Thereafter		97,355
		Total		$	138,948

LONGTERM_DEBT_INTEREST_EXPENSE

LONG-TERM DEBT / INTEREST EXPENSE	6 Months Ended
	Jun. 30, 2014
Debt Disclosure [Abstract]	'
LONG-TERM DEBT / INTEREST EXPENSE	'
	LONG-TERM DEBT / INTEREST EXPENSE
	Long-term debt consisted of the following:
			June 30,			December 31,
			2014			2013
			(unaudited)
			(in thousands)
		Senior Credit Facility	$	1,344,069		$	1,345,987
		Other	369			1,112
		Total debt	1,344,438			1,347,099
		Less: current maturities	(4,825		)	(5,443		)
		Long-term debt	$	1,339,613		$	1,341,656
	In 2013, the Company amended and restated its existing $1.4 billion term loan facility (the “Term Loan Facility”) to, among other amendments, increase borrowings by $252.5 million and extend the maturity date of the Term Loan Facility to March 2019. The Company also increased the amount available for borrowing under the $80.0 million revolving credit facility (the “Revolving Credit Facility” and, together with the Term Loan Facility, the “Senior Credit Facility”) to $130.0 million, extended the maturity date of the Revolving Credit Facility to March 2017, and effected changes in the interest rates applicable to amounts outstanding under the Revolving Credit Facility.
	For the six months ended June 30, 2014 and 2013, net interest expense was $23.2 million and $22.1 million, respectively, and consisted primarily of interest on outstanding borrowings under the Term Loan Facility. Interest under both the Term Loan Facility and the Revolving Credit Facility is based on variable rates. At both June 30, 2014 and December 31, 2013, the interest rate under the Term Loan Facility was 3.25%. The Revolving Credit Facility was undrawn and had outstanding letters of credit of $1.1 million at both June 30, 2014 and December 31, 2013. At both June 30, 2014 and December 31, 2013, the commitment fee on the undrawn portion of the Revolving Credit Facility was 0.5%, and the outstanding letters of credit fee was 2.50%.
	As of June 30, 2014, the Company believes that it is in compliance with all covenants under the Senior Credit Facility.

FINANCIAL_INSTRUMENTS

FINANCIAL INSTRUMENTS	6 Months Ended
	Jun. 30, 2014
Financial Instruments, Owned, at Fair Value [Abstract]	'
FINANCIAL INSTRUMENTS	'
	FINANCIAL INSTRUMENTS
	At June 30, 2014 and December 31, 2013, the Company’s financial instruments consisted of cash and cash equivalents, receivables, franchise notes receivable, accounts payable, certain accrued liabilities and long-term debt. The carrying amount of cash and cash equivalents, receivables, accounts payable and accrued liabilities approximates their respective fair values because of the short maturities of these instruments. Based on the interest rates currently available and their underlying risk, the carrying value of the franchise notes receivable approximates their respective fair values. These fair values are reflected net of reserves for uncollectible amounts. As considerable judgment is required to determine these estimates and assumptions, changes in the assumptions or methodologies may have an effect on these estimates. The Company determined the estimated fair values of its debt by using currently available market information. The fair value measurement for debt is classified as a Level 2 input on the fair value hierarchy, as defined in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013. The actual and estimated fair values of the Company’s financial instruments are as follows:
		30-Jun-14				31-Dec-13
		Carrying		Fair		Carrying		Fair
		Amount		Value		Amount		Value
		(unaudited)
		(in thousands)
	Cash and cash equivalents	$	118,545	$	118,545	$	226,217	$	226,217
	Receivables, net	142,864		142,864		144,833		144,833
	Franchise notes receivable, net	15,257		15,257		10,163		10,163
	Accounts payable	148,958		148,958		135,164		135,164
	Long-term debt (including current portion)	1,344,438		1,327,632		1,347,099		1,343,732

COMMITMENTS_AND_CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	6 Months Ended
	Jun. 30, 2014
Commitments and Contingencies Disclosure [Abstract]	'
COMMITMENTS AND CONTINGENCIES	'
	COMMITMENTS AND CONTINGENCIES
	Litigation
	The Company is engaged in various legal actions, claims and proceedings arising in the normal course of business, including claims related to breach of contracts, products liabilities, intellectual property matters and employment-related matters resulting from the Company’s business activities.
	The Company records accruals for outstanding legal matters when it believes it is probable that a loss will be incurred and the amount of such loss can be reasonably estimated. The Company evaluates, on a quarterly basis, developments in legal matters that could affect the amount of any accrual and developments that would make a loss contingency both probable and reasonably estimable. If a loss contingency is not both probable and estimable, the Company does not establish an accrued liability.  Currently, none of the Company’s accruals for outstanding legal matters are material individually or in the aggregate to the Company’s financial position. However, if the Company ultimately is required to make a payment in connection with an adverse outcome in any of the matters discussed below, it is possible that it could have a material adverse effect on the Company’s business, financial condition, results of operations or cash flows.
	The Company’s contingencies are subject to substantial uncertainties, including for each such contingency the following, among other factors: (i) the procedural status of the case; (ii) whether the case has or may be certified as a class action suit; (iii) the outcome of preliminary motions; (iv) the impact of discovery; (v) whether there are significant factual issues to be determined or resolved; (vi) whether the proceedings involve a large number of parties and/or parties and claims in multiple jurisdictions or jurisdictions in which the relevant laws are complex or unclear; (vii) the extent of potential damages, which are often unspecified or indeterminate; and (viii) the status of settlement discussions, if any, and the settlement posture of the parties.  Consequently, except as otherwise noted below with regard to a particular matter, the Company cannot predict with any reasonable certainty the timing or outcome of the legal matters described below, and the Company is unable to estimate a possible loss or range of loss.
	As a manufacturer and retailer of nutritional supplements and other consumer products that are ingested by consumers or applied to their bodies, the Company has been and is currently subjected to various product liability claims. Although the effects of these claims to date have not been material to the Company, it is possible that current and future product liability claims could have a material adverse effect on its business or financial condition, results of operations or cash flows. The Company currently maintains product liability insurance with a deductible/retention of $4.0 million per claim with an aggregate cap on retained loss of $10.0 million. The Company typically seeks and has obtained contractual indemnification from most parties that supply raw materials for its products or that manufacture or market products it sells. The Company also typically seeks to be added, and has been added, as an additional insured under most of such parties’ insurance policies.  The Company is also entitled to indemnification by Numico for certain losses arising from claims related to products containing ephedra or Kava Kava sold prior to December 5, 2003. However, any such indemnification or insurance is limited by its terms and any such indemnification, as a practical matter, is limited to the creditworthiness of the indemnifying party and its insurer, and the absence of significant defenses by the insurers. Consequently, the Company may incur material products liability claims, which could increase its costs and adversely affect its reputation, revenue and operating income.
	Hydroxycut Claims.    On May 1, 2009, the FDA issued a warning on several Hydroxycut-branded products manufactured by Iovate Health Sciences U.S.A., Inc. (“Iovate”) based on 23 reports of liver injuries from consumers who claimed to have used the products between 2002 and 2009. As a result, Iovate voluntarily recalled 14 Hydroxycut-branded products.
	Following the recall, the Company was named, among other defendants, in multiple lawsuits related to Hydroxycut-branded products in several states. Iovate previously accepted the Company’s tender request for defense and indemnification under its purchasing agreement with the Company in these matters. The Company’s ability to obtain full recovery in respect of any claims against the Company in connection with products manufactured by Iovate under the indemnity is dependent on Iovate’s insurance coverage, the creditworthiness of its insurer, and the absence of significant defenses by such insurer. To the extent the Company is not fully compensated by Iovate’s insurer, it can seek recovery directly from Iovate. The Company’s ability to fully recover such amounts may be limited by the creditworthiness of Iovate.
	As of June 30, 2014, there were 76 pending lawsuits related to Hydroxycut in which the Company had been named: 70 individual, largely personal injury claims and six putative class action cases, generally inclusive of claims of consumer fraud, misrepresentation, strict liability and breach of warranty.
	The United States Judicial Panel on Multidistrict Litigation consolidated pretrial proceedings of many of the pending actions in the Southern District of California (In re: Hydroxycut Marketing and Sales Practices Litigation, MDL No. 2087).
	In May 2013, the parties to the individual personal injury cases signed a Master Settlement Agreement, under which the Company is not required to make any payments. Settlement payments will be made exclusively by Iovate and dismissals are expected to be entered in these actions in the near term.
	The parties in the consolidated class actions reached a settlement, but the Court denied final approval of that settlement in December 2013. The parties have since reached a revised settlement, which remains subject to Court approval. The Company is not required to make any payments under the current settlement agreement. Following the resolution of the individual personal injury cases and the settlement of the consolidated class action suits, all of the Hydroxycut claims currently pending against the Company will be resolved without any payment by the Company.
	DMAA / Aegeline Claims.  Prior to December 2013, the Company sold products manufactured by third parties that contained derivatives from geranium known as 1.3-dimethylpentylamine/ dimethylamylamine/13-dimethylamylamine, or “DMAA,” which were recalled from its stores in November 2013, and/or Aegeline, a compound extracted from bael trees.  As of June 30, 2014, the Company was named in 20 lawsuits involving products containing DMAA and/or Aegeline, including 17 personal injury cases and three putative class action cases.  The proceedings associated with these cases, which generally seek indeterminate money damages, are in the early stages, and any liabilities that may arise from these matters are not probable or reasonably estimable at this time. The Company is contractually entitled to indemnification by its third-party vendor with regard to these matters, although the Company’s ability to obtain full recovery in respect of any such claims against it is dependent upon the creditworthiness of the vendor and/or its insurance coverage and the absence of any significant defenses available to its insurer.
	California Wage and Break Claims.    On November 4, 2008, 98 plaintiffs filed individual claims against the Company in the Superior Court of the State of California for the County of Orange, which was removed to the U.S. District Court, Central District of California on February 17, 2009. Each of the plaintiffs had previously been a member of a purported class in a lawsuit filed against the Company in 2007 and resolved in September 2009. The plaintiffs allege that they were not provided all of the rest and meal periods to which they were entitled under California law, and further allege that the Company failed to pay them split shift and overtime compensation to which they were entitled under California law.  The plaintiffs also allege derivative claims for inaccurate wage statements, failure to pay wages due at termination, and penalty claims under the California Labor Code.  In June 2013, a trial was conducted with respect to the claims of seven of the plaintiffs.  The jury returned a verdict in favor of the Company on all claims submitted to the jury, and the Court entered an order in favor of the Company on the one claim submitted to the Court.  The claims of five other plaintiffs have been resolved and the claims of eighty-six plaintiffs remain, with respect to which discovery is ongoing.  As any liabilities that may arise from these matters are not probable or reasonably estimable at this time, no liability has been accrued in the accompanying financial statements.
	On July 21, 2011, Charles Brewer, on behalf of himself and all others similarly situated, sued General Nutrition Corporation in federal court, alleging state and federal wage and hour claims (U.S. District Court, Northern District of California, Case No. 11CV3587). On October 7, 2011, plaintiff filed an eight-count amended complaint alleging, inter alia, meal, rest break and overtime violations. On October 21, 2011, the Company filed a motion to dismiss the complaint and on December 14, 2011 the court dismissed count six (the federal overtime claim) giving plaintiffs an opportunity to amend the complaint within thirty days.  On January 13, 2012, plaintiff filed a Second Amended complaint.  On September 18, 2012, Plaintiff filed a Motion for Conditional Certification and on January 7, 2013, the Court conditionally certified a Fair Labor Standards Act class with respect to one of Plaintiff’s claims. As any liabilities that may arise from these matters are not probable or reasonably estimable at this time, no liability has been accrued in the accompanying financial statements.
	On February 29, 2012, former Senior Store Manager, Elizabeth Naranjo, individually and on behalf of all others similarly situated sued General Nutrition Corporation in the Superior Court of the State of California for the County of Alameda (Case No. RG 12619626).  The complaint contains eight causes of action, alleging, inter alia, meal, rest break, and overtime violations. As any liabilities that may arise from these matters are not probable or reasonably estimable at this time, no liability has been accrued in the accompanying financial statements.
	FLSA Matters.    On June 29, 2010, Dominic Vargas and Anne Hickok, on behalf of themselves and all others similarly situated, sued General Nutrition Corporation and the Company in federal court (U.S. District Court, Western District of Pennsylvania, Case No. 2:5-mc-2025). The two-count complaint alleges, generally, that plaintiffs were required to perform work on an uncompensated basis and that the Company failed to pay overtime for such work. The second count of the complaint alleges the Company retaliated against plaintiffs when they complained about the overtime policy. The Company filed a motion to dismiss count II of the Complaint and on January 6, 2011 the court granted the motion. In fall, 2011, plaintiffs filed their Motion for Class Certification. On August 16, 2012, the Court ruled on the motion, granting in part and denying in part, the motion.  Class notice was mailed to putative class members in November 2012 and discovery regarding opt-in plaintiffs is ongoing. As of June 30, 2014, an immaterial liability has been accrued in the accompanying financial statements.
	Jason Olive v. General Nutrition Corp. On April 11, 2012, Jason Olive filed a complaint in the Superior Court of California, County of Los Angeles (Case No. BC482686), for misappropriation of likeness in which the plaintiff alleges that the Company continued to use his image in stores after the expiration of the license to do so in violation of common law and California statutes. Plaintiff is seeking compensatory, punitive and statutory damages and attorneys’ fees and costs, and a trial in this matter is currently scheduled for December 2014. As of June 30, 2014, an immaterial liability has been accrued in the accompanying financial statements.
	Commitments
	In addition to operating leases obtained in the normal course of business, the Company maintains certain purchase commitments with various vendors to ensure its operational needs are fulfilled.  As of June 30, 2014, such future purchase commitments consisted of $4.9 million. Other commitments related to the Company’s business operations cover varying periods of time and are not significant. All of these commitments are expected to be fulfilled with no adverse consequences to the Company’s operations or financial condition.
	Environmental Compliance
	In March 2008, the South Carolina Department of Health and Environmental Control (the “DHEC”) requested that the Company investigate contamination associated with historical activities at its South Carolina facility. These investigations have identified chlorinated solvent impacts in soils and groundwater that extend offsite from the facility. The Company entered into a Voluntary Cleanup Contract with the DHEC regarding the matter on September 24, 2012. Pursuant to such contract, the Company will submit a plan for additional investigations to the DHEC and will implement the plan upon DHEC’s approval. After the Company completes the investigations to understand the extent of the chlorinated solvent impacts, the Company will develop appropriate remedial measures for DHEC approval. At this stage of the investigation, however, it is not possible to estimate the timing and extent of any remedial action that may be required, the ultimate cost of remediation, or the amount of the Company’s potential liability, therefore no liability is recorded.
	In addition to the foregoing, the Company is subject to numerous federal, state, local and foreign environmental and health and safety laws and regulations governing its operations, including the handling, transportation and disposal of the Company’s non-hazardous and hazardous substances and wastes, as well as emissions and discharges from its operations into the environment, including discharges to air, surface water and groundwater. Failure to comply with such laws and regulations could result in costs for remedial actions, penalties or the imposition of other liabilities. New laws, changes in existing laws or the interpretation thereof, or the development of new facts or changes in their processes could also cause the Company to incur additional capital and operating expenditures to maintain compliance with environmental laws and regulations and environmental permits.  The Company is also subject to laws and regulations that impose liability and cleanup responsibility for releases of hazardous substances into the environment without regard to fault or knowledge about the condition or action causing the liability. Under certain of these laws and regulations, such liabilities can be imposed for cleanup of previously owned or operated properties, or for properties to which substances or wastes were sent in connection with current or former operations at its facilities. The presence of contamination from such substances or wastes could also adversely affect the Company’s ability to sell or lease its properties, or to use them as collateral for financing. From time to time, the Company has incurred costs and obligations for correcting environmental and health and safety noncompliance matters and for remediation at or relating to certain of the Company’s properties or properties at which the Company’s waste has been disposed.  However, compliance with the provisions of national, state and local environmental laws and regulations has not had a material effect upon the Company’s capital expenditures, earnings, financial position, liquidity or competitive position. The Company believes it has complied with, and is currently complying with, its environmental obligations pursuant to environmental and health and safety laws and regulations and that any liabilities for noncompliance will not have a material adverse effect on its business, financial performance or cash flows. However, it is difficult to predict future liabilities and obligations, which could be material.

STOCKBASED_COMPENSATION_PLANS

STOCK-BASED COMPENSATION PLANS	6 Months Ended
	Jun. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
STOCK-BASED COMPENSATION PLANS	'
	STOCK-BASED COMPENSATION PLANS
	The Company has outstanding stock-based compensation awards that were granted by the Compensation Committee (the “Compensation Committee”) of Holdings’ board of directors under the following two stock-based employee compensation plans:
	•	the GNC Holdings, Inc. 2011 Stock and Incentive Plan (the “2011 Stock Plan”) adopted in March 2011; and
	•	the GNC Acquisition Holdings Inc. 2007 Stock Incentive Plan adopted in March 2007 (as amended, the “2007 Stock Plan”).
	Both plans have provisions that allow for the granting of stock options, restricted stock and other stock-based awards and are available to certain eligible employees, directors, consultants or advisors as determined by the Compensation Committee. Stock options under the plans were granted with exercise prices at or above fair market value on the date of grant, typically vest over a four- or five-year period, and expire seven or ten years from the date of grant.
	Up to 8.5 million shares of common stock may be issued under the 2011 Stock Plan (subject to adjustment to reflect certain transactions and events specified in the 2011 Stock Plan for any award grant). If any award granted under the 2011 Stock Plan expires, terminates or is cancelled without having been exercised in full, the number of shares underlying such unexercised award will again become available for awards under the 2011 Stock Plan. The total number of shares of common stock available for awards under the 2011 Stock Plan will be reduced by (i) the total number of stock options or stock appreciation rights exercised, regardless of whether any of the shares of common stock underlying such awards are not actually issued to the participant as the result of a net settlement, and (ii) any shares of common stock used to pay any exercise price or tax withholding obligation. In addition, the number of shares of common stock that are subject to restricted stock, performance shares or other stock-based awards that are not subject to the appreciation of the value of a share of common stock (“Full Share Awards”) that may be granted under the 2011 Stock Plan is limited by counting shares granted pursuant to such awards against the aggregate share reserve as 1.8 shares for every share granted. If any stock option, stock appreciation right or other stock-based award that is not a Full Share Award is cancelled, expires or terminates unexercised for any reason, the shares covered by such awards will again be available for the grant of awards under the 2011 Stock Plan. If any shares of common stock that are subject to restricted stock, performance shares or other stock-based awards that are Full Share Awards are forfeited for any reason, 1.8 shares of common stock for each Full Share Award forfeited will again be available for the grant of awards under the 2011 Stock Plan.
	The Company will not grant any additional awards under the 2007 Stock Plan.  No stock appreciation rights, restricted stock, deferred stock or performance shares were granted under the 2007 Stock Plan.
	The Company utilizes the Black Scholes model to calculate the fair value of options under both the 2011 Stock Plan and the 2007 Stock Plan. The grant-date fair value of the Company’s restricted stock awards and restricted stock units is based on the closing price of a share of the Company’s common stock on the New York Stock Exchange on the date of the grant. The resulting compensation cost is recognized in the Company’s financial statements over the vesting period. The Company recognized $3.4 million and $3.9 million of total non-cash stock-based compensation expense for the six months ended June 30, 2014 and 2013, respectively. At June 30, 2014, there was approximately $17.8 million of total unrecognized compensation cost related to non-vested stock-based compensation for all awards previously made that are expected to be recognized over a weighted average period of approximately 1.5 years. All expense for the stock-based compensation plans is recorded to paid-in-capital.
	During the six months ended June 30, 2014, the total intrinsic value of options exercised and stock awards converted was $4.6 million and the total amount received by Holdings from the exercise of options and stock awards converted was $1.9 million. The total tax impact associated with the exercise of options and stock awards converted for the six months ended June 30, 2014 was a benefit of $1.7 million, of which $1.2 million was recorded to paid-in-capital.
	During the six months ended June 30, 2013, the total intrinsic value of options exercised and stock awards converted was $18.7 million, and the total amount received by Holdings from the exercise of options and stock awards converted was $6.3 million. The total tax impact associated with the exercise of options and stock awards converted for the six months ended June 30, 2013 was a benefit of $7.0 million, of which $6.3 million was recorded to paid-in-capital.
	Stock Options
	The following table sets forth a summary of stock options under all plans for the six months ended June 30, 2014:
		Total Options		Weighted		Weighted		Aggregate
				Average		Average		Intrinsic
				Exercise		Remaining		Value (in
				Price		Contractual Term		thousands)
						(in years)
	Outstanding at December 31, 2013	1,887,154		$	24.14
	Exercised	(108,024	)	17.04
	Forfeited	(40,814	)	31.2
	Outstanding at June 30, 2014	1,738,316		$	24.41	5.1		$	16,844
	Exercisable at June 30, 2014	743,785		$	21.32	5.2		$	9,506
	There were no options granted during the six months ended June 30, 2014. The weighted average fair value per share of options granted during the six months ended June 30, 2013 was $14.01. Fair value of options vested during the six months ended June 30, 2014 and 2013 was $1.6 million and $2.0 million, respectively.
	The Black Scholes model utilizes the following assumptions in determining a fair value: price of underlying stock, award exercise price, expected term, risk-free interest rate, expected dividend yield and expected stock price volatility over the award’s expected term. Due to the utilization of these assumptions, the existing models do not necessarily represent the definitive fair value of awards for future periods. As the initial public offering (the “IPO”) occurred during the second quarter of 2011, the option term has been estimated by considering both the vesting period, which typically for both plans has been four or five years, and the contractual term, which historically has been either seven or ten years. Prior to the IPO, the fair value of the common stock was estimated based upon the net enterprise value of the Company, discounted to reflect the lack of liquidity and control associated with the stock.  Since the consummation of the IPO, the fair value of the common stock has been based upon the closing price of the common stock as reported on the New York Stock Exchange. Volatility is estimated based upon the current peer group average utilized by the Company.
	Restricted Stock Awards
	The following table sets forth a summary of restricted stock awards granted under the 2011 Stock Plan and related information for the six months ended June 30, 2014:
		Restricted		Weighted
		Stock		Average
				Grant-Date
				Fair Value
	Outstanding at December 31, 2013	114,981		$	25.16
	Granted	10,404		36.52
	Vested	(20,436	)	32.4
	Forfeited	(4,718	)	29.36
	Outstanding at June 30, 2014	100,231		$	24.67
	Restricted Stock Units – Time Vesting and Performance Vesting
	Under the 2011 Stock Plan, the Company granted time vesting and performance vesting restricted stock units. Time vesting restricted stock units vest over a period of three years. Performance vesting restricted stock units vest based on the passage of time and the achievement of certain criteria; based on the extent to which the targets are achieved, vested shares may range from 0% to 200% of the original share amount. The unrecognized compensation cost related to the performance vesting restricted stock units is adjusted as necessary to reflect changes in the probability that the vesting criteria will be achieved.
	The following table sets forth a summary of restricted stock units and performance stock units granted under the 2011 Stock Plan and related information for the six months ended June 30, 2014:
		Time		Weighted		Performance			Weighted
		Vesting		Average		Vesting			Average
		Restricted		Grant-Date		Restricted			Grant-Date
		Stock Units		Fair Value		Stock Units			Fair Value
	Outstanding at December 31, 2013	141,298		$	40.81	55,366			$	45.94
	Granted	151,412		43.99		130,798			44.62
	Vested	(1,014	)	45.57		—			—
	Forfeited	(3,778	)	35.72		(2,074	)		42.19
	Outstanding at June 30, 2014	287,918		$	42.53	184,090			$	45.04

SEGMENTS

SEGMENTS	6 Months Ended
	Jun. 30, 2014
Segment Reporting [Abstract]	'
SEGMENTS	'
	SEGMENTS
	The Company has three reportable segments, each of which represents an identifiable component of the Company for which separate financial information is available. This information is utilized by management to assess performance and allocate assets accordingly. The Company’s management evaluates segment operating results based on several indicators. The primary key performance indicators are sales and operating income or loss for each segment. Operating income or loss, as evaluated by management, excludes certain items that are managed at the consolidated level, such as distribution and warehousing, impairments and other corporate costs. The Retail reportable segment includes the Company’s corporate store operations in the United States, Canada, Puerto Rico, and Ireland, and its websites GNC.com, Lucky Vitamin, and Discount Supplements. The Franchise reportable segment represents the Company’s franchise operations, both domestically and internationally. The Manufacturing/Wholesale reportable segment represents the Company’s manufacturing operations in South Carolina and the Wholesale sales business. This segment supplies the Retail and Franchise segments, along with various third parties, with finished products for sale. The Warehousing and Distribution and Corporate costs represent the Company’s administrative expenses. The accounting policies of the segments are the same as those described in the “Basis of Presentation and Summary of Significant Accounting Policies.”
	The following table represents key financial information of the Company’s segments:
		Three months ended June 30,						Six months ended June 30,
		2014			2013			2014			2013
		(unaudited)
		(in thousands)
	Revenue:
	Retail	$	505,508		$	502,490		$	1,014,506		$	995,957
	Franchise	110,142			110,560			216,476			218,446
	Manufacturing/Wholesale:
	Intersegment revenues	63,858			67,546			132,616			133,017
	Third Party	59,566			63,226			121,510			126,563
	Subtotal Manufacturing/Wholesale	123,424			130,772			254,126			259,580
	Subtotal segment revenues	739,074			743,822			1,485,108			1,473,983
	Elimination of intersegment revenues	(63,858		)	(67,546		)	(132,616		)	(133,017		)
	Total revenue	$	675,216		$	676,276		$	1,352,492		$	1,340,966
	Operating income:
	Retail	$	94,425		$	100,344		$	188,545		$	198,927
	Franchise	41,116			36,650			81,313			75,075
	Manufacturing/Wholesale	22,932			25,507			46,443			48,434
	Unallocated corporate and other costs:
	Warehousing and distribution costs	(17,047		)	(16,869		)	(32,981		)	(33,224		)
	Corporate costs	(20,375		)	(21,961		)	(41,014		)	(41,021		)
	Subtotal unallocated corporate and
	other costs	(37,422		)	(38,830		)	(73,995		)	(74,245		)
	Total operating income	121,051			123,671			242,306			248,191
	Interest expense, net	11,675			11,101			23,206			22,116
	Income before income taxes	$	109,376		$	112,570		$	219,100		$	226,075

INCOME_TAXES

INCOME TAXES	6 Months Ended
	Jun. 30, 2014
Income Tax Disclosure [Abstract]	'
INCOME TAXES	'
	INCOME TAXES
	The Company recognized $79.3 million of income tax expense (or 36.2% of pre-tax income) during the six months ended June 30, 2014 compared to $81.7 million (or 36.2% of pre-tax income) for the same period in 2013.
	The Company files a consolidated U.S. federal tax return and various consolidated and separate tax returns as prescribed by the tax laws of the state, local and international jurisdictions in which it operates. The Company’s 2010 and 2011 federal income tax returns have been examined by the Internal Revenue Service. The Company has various state, local and international jurisdiction tax years open to examination (the earliest open period is 2005), and the Company also has certain state and local jurisdictions currently under audit. As of June 30, 2014, the Company believes that it has appropriately reserved for potential federal, state and international income tax exposures.
	At June 30, 2014 and December 31, 2013, the Company had $11.2 million and $10.8 million of unrecognized tax benefits, respectively. As of June 30, 2014, the Company is not aware of any tax positions for which it is reasonably possible that the amounts of unrecognized tax benefits will significantly increase or decrease within the next 12 months. The amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate is approximately $11.2 million. The Company recognizes accrued interest and penalties related to unrecognized tax benefits in income tax expense. The Company had accrued approximately $4.2 million at both June 30, 2014 and December 31, 2013, respectively, for potential interest and penalties associated with uncertain tax positions. To the extent interest and penalties are not assessed with respect to the ultimate settlement of uncertain tax positions, amounts previously accrued will be reduced and reflected as a reduction of the overall income tax provision.

SUBSEQUENT_EVENTS

SUBSEQUENT EVENTS	6 Months Ended
	Jun. 30, 2014
Subsequent Events [Abstract]	'
SUBSEQUENT EVENTS	'
	SUBSEQUENT EVENTS
	On July 24, 2014, the board of directors authorized and declared a cash dividend for the third quarter of 2014 of $0.16 per share of common stock, payable on or about September 26, 2014 to stockholders of record as of the close of business on September 12, 2014.

BASIS_OF_PRESENTATION_AND_SUMM1

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	6 Months Ended
	Jun. 30, 2014
Accounting Policies [Abstract]	'
Principles of Consolidation	'
	Principles of Consolidation. The consolidated financial statements include the accounts of Holdings and all of its subsidiaries. All material intercompany transactions have been eliminated in consolidation.
	The Company has no relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off balance sheet arrangements or other contractually narrow or limited purposes.
Use of Estimates	'
	Use of Estimates.  The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions. Accordingly, these estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. Some of the most significant estimates pertaining to the Company include the valuation of inventories, the allowance for doubtful accounts and income taxes. On a regular basis, management reviews its estimates utilizing currently available information, changes in facts and circumstances, historical experience and reasonable assumptions. After such reviews and if deemed appropriate, those estimates are adjusted accordingly. Actual results could differ from those estimates.
Recent Accounting Pronouncements	'
	Recent Accounting Pronouncements
	In July 2013, the Financial Accounting Standards Board ("FASB") issued accounting standard ASU 2013-11, regarding the presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. This standard requires entities to present an unrecognized tax benefit as a reduction of a deferred tax asset for a net operating loss (“NOL”) or tax credit carryforward whenever the NOL or tax credit carryforward would be available to reduce the additional taxable income or tax due if the tax position is disallowed. This accounting standard update requires entities to assess whether to net the unrecognized tax benefit with a deferred tax asset as of the reporting date. This guidance is effective for fiscal years beginning after December 15, 2013, with early adoption permitted. The Company adopted this guidance during the first quarter of 2014. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements.
	In May 2014, the FASB issued accounting standard ASU 2014-09, which updates revenue recognition guidance relating to contracts with customers. This standard states that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This standard is effective for fiscal years beginning after December 15, 2016. The Company is currently evaluating the impact this guidance will have on the consolidated financial statements.
	In June 2014, the FASB issued accounting standard ASU 2014-12, which updates guidance on performance stock awards. The update states that for any award that has a performance target that affects vesting and that could be achieved after the requisite period, that performance target should still be treated as a performance condition. This standard is effective for fiscal years beginning after December 15, 2015. The Company is currently evaluating the impact this guidance will have on the consolidated financial statements.

INVENTORIES_Tables

INVENTORIES (Tables)	6 Months Ended
	Jun. 30, 2014
Inventory Disclosure [Abstract]	'
Schedule of Net Carrying Value of Inventories	'
	The net carrying value of inventories consisted of the following:
		30-Jun-14		31-Dec-13
		(unaudited)
		(in thousands)
	Finished product ready for sale	$	503,280	$	458,366
	Work-in-process, bulk product and raw materials	77,050		81,575
	Packaging supplies	8,045		7,975
	Total	$	588,375	$	547,916

GOODWILL_AND_INTANGIBLE_ASSETS1

GOODWILL AND INTANGIBLE ASSETS, NET (Tables)	6 Months Ended
	Jun. 30, 2014
Goodwill and Intangible Assets Disclosure [Abstract]	'
Schedule of Goodwill Activity	'
	The following table summarizes the Company’s goodwill activity:
		Retail				Franchising			Manufacturing/				Total
									Wholesale
		(in thousands)
	Balance at December 31, 2013	346,202				$	117,303		$	202,841			$	666,346
	Acquired franchise stores	860				—			—				860
	Acquisition of The Health Store	6,853				—			—				6,853
	Translation effect of exchange rates	741				—			—				741
	Balance at June 30, 2014 (unaudited)	$	354,656			$	117,303		$	202,841			$	674,800
Schedule of Intangible Asset Activity	'
	Intangible assets other than goodwill consisted of the following:
		Retail				Franchise			Operating				Other				Total
		Brand				Brand			Agreements				Intangibles
		(in thousands)
	Balance at December 31, 2013	$	500,000			$	220,000		$	125,665			$	17,109			$	862,774
	Acquired franchise stores	—				—			—				515				515
	Acquisition of The Health Store	—				—			—				788				788
	Amortization expense	—				—			(3,326		)		(2,072		)		(5,398		)
	Translation effect of exchange rates	—				—			—				269				269
	Balance at June 30, 2014 (unaudited)	$	500,000			$	220,000		$	122,339			$	16,609			$	858,948
Schedule of Gross Carrying Amount and Accumulated Amortization for Each Major Intangible Asset	'
	The following table reflects the gross carrying amount and accumulated amortization for each major intangible asset:
		Weighted-			June 30, 2014											December 31, 2013
		Average
		Life			Cost			Accumulated				Carrying				Cost				Accumulated			Carrying
								Amortization				Amount								Amortization			Amount
					(unaudited)
					(in thousands)
	Brands - retail	—			$	500,000		$	—			$	500,000			$	500,000			$	—		$	500,000
	Brands - franchise	—			220,000			—				220,000				220,000				—			220,000
	Retail agreements	30.3			31,000			(7,828		)		23,172				31,000				(7,301		)	23,699
	Franchise agreements	25			70,000			(20,417		)		49,583				70,000				(19,017		)	50,983
	Manufacturing agreements	25			70,000			(20,417		)		49,583				70,000				(19,017		)	50,983
	Other intangibles	8.1			21,429			(5,855		)		15,574				20,327				(3,995		)	16,332
	Franchise rights	3			5,978			(4,942		)		1,036				5,463				(4,686		)	777
	Total	23.4			$	918,407		$	(59,459	)		$	858,948			$	916,790			$	(54,016	)	$	862,774
Schedule of Future Estimated Amortization Expense of Other Intangible Assets, Net, with Definite Lives	'
	The following table represents future estimated amortization expense of intangible assets with finite lives at June 30, 2014:
		Years ending December 31,		Estimated
				amortization
				expense
				(unaudited)
				(in thousands)
		2014		$	5,483
		2015		10,756
		2016		9,870
		2017		7,784
		2018		7,700
		Thereafter		97,355
		Total		$	138,948

LONGTERM_DEBT_INTEREST_EXPENSE1

LONG-TERM DEBT / INTEREST EXPENSE (Tables)	6 Months Ended
	Jun. 30, 2014
Debt Disclosure [Abstract]	'
Schedule of Long-term Debt	'
	Long-term debt consisted of the following:
			June 30,			December 31,
			2014			2013
			(unaudited)
			(in thousands)
		Senior Credit Facility	$	1,344,069		$	1,345,987
		Other	369			1,112
		Total debt	1,344,438			1,347,099
		Less: current maturities	(4,825		)	(5,443		)
		Long-term debt	$	1,339,613		$	1,341,656

FINANCIAL_INSTRUMENTS_Tables

FINANCIAL INSTRUMENTS (Tables)	6 Months Ended
	Jun. 30, 2014
Financial Instruments, Owned, at Fair Value [Abstract]	'
Schedule of Carrying Amount and Estimated Fair Values of the Financial Instruments	'
	The actual and estimated fair values of the Company’s financial instruments are as follows:
		30-Jun-14				31-Dec-13
		Carrying		Fair		Carrying		Fair
		Amount		Value		Amount		Value
		(unaudited)
		(in thousands)
	Cash and cash equivalents	$	118,545	$	118,545	$	226,217	$	226,217
	Receivables, net	142,864		142,864		144,833		144,833
	Franchise notes receivable, net	15,257		15,257		10,163		10,163
	Accounts payable	148,958		148,958		135,164		135,164
	Long-term debt (including current portion)	1,344,438		1,327,632		1,347,099		1,343,732

STOCKBASED_COMPENSATION_PLANS_

STOCK-BASED COMPENSATION PLANS (Tables)	6 Months Ended
	Jun. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Schedule of Stock Options Under All Plans	'
	The following table sets forth a summary of stock options under all plans for the six months ended June 30, 2014:
		Total Options		Weighted		Weighted		Aggregate
				Average		Average		Intrinsic
				Exercise		Remaining		Value (in
				Price		Contractual Term		thousands)
						(in years)
	Outstanding at December 31, 2013	1,887,154		$	24.14
	Exercised	(108,024	)	17.04
	Forfeited	(40,814	)	31.2
	Outstanding at June 30, 2014	1,738,316		$	24.41	5.1		$	16,844
	Exercisable at June 30, 2014	743,785		$	21.32	5.2		$	9,506
Summary of Restricted Stock Awards Granted Under the 2011 Stock Plan and Related Information	'
	The following table sets forth a summary of restricted stock awards granted under the 2011 Stock Plan and related information for the six months ended June 30, 2014:
		Restricted		Weighted
		Stock		Average
				Grant-Date
				Fair Value
	Outstanding at December 31, 2013	114,981		$	25.16
	Granted	10,404		36.52
	Vested	(20,436	)	32.4
	Forfeited	(4,718	)	29.36
	Outstanding at June 30, 2014	100,231		$	24.67
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity	'
	The following table sets forth a summary of restricted stock units and performance stock units granted under the 2011 Stock Plan and related information for the six months ended June 30, 2014:
		Time		Weighted		Performance			Weighted
		Vesting		Average		Vesting			Average
		Restricted		Grant-Date		Restricted			Grant-Date
		Stock Units		Fair Value		Stock Units			Fair Value
	Outstanding at December 31, 2013	141,298		$	40.81	55,366			$	45.94
	Granted	151,412		43.99		130,798			44.62
	Vested	(1,014	)	45.57		—			—
	Forfeited	(3,778	)	35.72		(2,074	)		42.19
	Outstanding at June 30, 2014	287,918		$	42.53	184,090			$	45.04

SEGMENTS_Tables

SEGMENTS (Tables)	6 Months Ended
	Jun. 30, 2014
Segment Reporting [Abstract]	'
Schedule of Key Financial Information of the Segments	'
	The following table represents key financial information of the Company’s segments:
		Three months ended June 30,						Six months ended June 30,
		2014			2013			2014			2013
		(unaudited)
		(in thousands)
	Revenue:
	Retail	$	505,508		$	502,490		$	1,014,506		$	995,957
	Franchise	110,142			110,560			216,476			218,446
	Manufacturing/Wholesale:
	Intersegment revenues	63,858			67,546			132,616			133,017
	Third Party	59,566			63,226			121,510			126,563
	Subtotal Manufacturing/Wholesale	123,424			130,772			254,126			259,580
	Subtotal segment revenues	739,074			743,822			1,485,108			1,473,983
	Elimination of intersegment revenues	(63,858		)	(67,546		)	(132,616		)	(133,017		)
	Total revenue	$	675,216		$	676,276		$	1,352,492		$	1,340,966
	Operating income:
	Retail	$	94,425		$	100,344		$	188,545		$	198,927
	Franchise	41,116			36,650			81,313			75,075
	Manufacturing/Wholesale	22,932			25,507			46,443			48,434
	Unallocated corporate and other costs:
	Warehousing and distribution costs	(17,047		)	(16,869		)	(32,981		)	(33,224		)
	Corporate costs	(20,375		)	(21,961		)	(41,014		)	(41,021		)
	Subtotal unallocated corporate and
	other costs	(37,422		)	(38,830		)	(73,995		)	(74,245		)
	Total operating income	121,051			123,671			242,306			248,191
	Interest expense, net	11,675			11,101			23,206			22,116
	Income before income taxes	$	109,376		$	112,570		$	219,100		$	226,075

NATURE_OF_BUSINESS_Details

NATURE OF BUSINESS (Details) (USD $)	1 Months Ended	6 Months Ended	8 Months Ended		1 Months Ended	0 Months Ended
	Nov. 30, 2013	Jun. 30, 2014	Jun. 30, 2014	Jun. 30, 2014	Oct. 31, 2013	Apr. 17, 2014	Apr. 17, 2014
		segment		Minimum	Discount Supplements	The Health Store	The Health Store
				country			store
General nature of business and recent significant transactions	'	'	'	'	'	'	'
Number of primary segments	'	3	'	'	'	'	'
Number of international countries in which franchise stores are located (over 50 countries)	'	'	'	50	'	'	'
Recent Significant Transactions	'	'	'	'	'	'	'
Amount of shares authorized to repurchase	$500,000,000	'	'	'	'	'	'
Amount of shares repurchased	'	190,200,000	249,300,000	'	'	'	'
Aggregate purchase price of acquisition	'	'	'	'	$33,300,000	$8,900,000	'
Number of Stores	'	'	'	'	'	'	9

INVENTORIES_Details

INVENTORIES (Details) (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Inventory Disclosure [Abstract]	'	'
Finished product ready for sale	$503,280	$458,366
Work-in-process, bulk product and raw materials	77,050	81,575
Packaging supplies	8,045	7,975
Total	$588,375	$547,916

GOODWILL_AND_INTANGIBLE_ASSETS2

GOODWILL AND INTANGIBLE ASSETS, NET (Details) (USD $)	Jun. 30, 2014	Dec. 31, 2013	Jun. 30, 2014	Jun. 30, 2013	Apr. 17, 2014	Apr. 17, 2014
			Franchise Stores	Franchise Stores	The Health Store	The Health Store
			store	store
Acquisitions	'	'	'	'	'	'
Number of franchise stores acquired	'	'	17	11	'	'
Total purchase prices associated with acquisitions	'	'	$2,200,000	$2,000,000	$8,900,000	'
Cash paid	'	'	1,400,000	1,200,000	'	'
Goodwill	674,800,000	666,346,000	'	'	'	6,900,000
Amortizable intangible assets	'	'	'	'	'	800,000
Working capital	'	'	'	'	'	$300,000

GOODWILL_AND_INTANGIBLE_ASSETS3

GOODWILL AND INTANGIBLE ASSETS, NET (Details 2) (USD $)	6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014
Goodwill [Roll Forward]	'
Balance at December 31, 2013	$666,346
Translation effect of exchange rates	741
Balance at June 30, 2014 (unaudited)	674,800
Acquired Franchise Stores	'
Goodwill [Roll Forward]	'
Acquired goodwill	860
Acquisition of The Health Store	'
Goodwill [Roll Forward]	'
Acquired goodwill	6,853
Retail	'
Goodwill [Roll Forward]	'
Balance at December 31, 2013	346,202
Translation effect of exchange rates	741
Balance at June 30, 2014 (unaudited)	354,656
Retail | Acquired Franchise Stores	'
Goodwill [Roll Forward]	'
Acquired goodwill	860
Retail | Acquisition of The Health Store	'
Goodwill [Roll Forward]	'
Acquired goodwill	6,853
Franchising	'
Goodwill [Roll Forward]	'
Balance at December 31, 2013	117,303
Translation effect of exchange rates	0
Balance at June 30, 2014 (unaudited)	117,303
Franchising | Acquired Franchise Stores	'
Goodwill [Roll Forward]	'
Acquired goodwill	0
Franchising | Acquisition of The Health Store	'
Goodwill [Roll Forward]	'
Acquired goodwill	0
Manufacturing/ Wholesale	'
Goodwill [Roll Forward]	'
Balance at December 31, 2013	202,841
Translation effect of exchange rates	0
Balance at June 30, 2014 (unaudited)	202,841
Manufacturing/ Wholesale | Acquired Franchise Stores	'
Goodwill [Roll Forward]	'
Acquired goodwill	0
Manufacturing/ Wholesale | Acquisition of The Health Store	'
Goodwill [Roll Forward]	'
Acquired goodwill	$0

GOODWILL_AND_INTANGIBLE_ASSETS4

GOODWILL AND INTANGIBLE ASSETS, NET (Details 3) (USD $)	6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2014	Jun. 30, 2014	Jun. 30, 2014	Dec. 31, 2013	Jun. 30, 2014	Dec. 31, 2013
		Operating Agreements	Other Intangibles	Retail Brand	Retail Brand	Franchise Brand	Franchise Brand
Indefinite-lived Intangible Assets [Roll Forward]	'	'	'	'	'	'	'
Balance at beginning of the period (in usd)	$720,000	'	'	$500,000	$500,000	$220,000	$220,000
Balance at the end of the period (unaudiited) (in usd)	720,000	'	'	500,000	500,000	220,000	220,000
Finite-lived Intangible Assets [Roll Forward]	'	'	'	'	'	'	'
Balance at beginning of the period (in usd)	'	125,665	17,109	'	'	'	'
Acquired franchise stores	515	0	515	'	'	'	'
Acquisitions	788	0	788	'	'	'	'
Amortization expense	-5,398	-3,326	-2,072	'	'	'	'
Translation effect of exchange rates	269	0	269	'	'	'	'
Balance at the end of the period (unaudited) (in usd)	138,948	122,339	16,609	'	'	'	'
Finite-Lived and Indefinite Lived Intangible Assets [Roll Forward]	'	'	'	'	'	'	'
Balance at beginning of the period (in usd)	862,774	'	'	'	'	'	'
Balance at the end of the period (in usd)	$858,948	'	'	'	'	'	'

GOODWILL_AND_INTANGIBLE_ASSETS5

GOODWILL AND INTANGIBLE ASSETS, NET (Details 4) (USD $)	6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Dec. 31, 2013
Finite Lived and Indefinite Lived Intangible Assets	'	'
Balance at beginning of the period (in usd)	$720,000	'
Balance at the end of the period (unaudiited) (in usd)	720,000	'
Finite-Lived Intangible Asset, Useful Life	'23 years 4 months 24 days	'
Finite-Lived Intangible Assets, Accumulated Amortization	-59,459	-54,016
Finite-Lived Intangible Assets, Carrying Amount	138,948	'
Intangible Assets, Gross (Excluding Goodwill)	918,407	916,790
Intangible Assets, Net (Excluding Goodwill)	858,948	862,774
Operating Agreements	'	'
Finite Lived and Indefinite Lived Intangible Assets	'	'
Finite-Lived Intangible Assets, Carrying Amount	122,339	125,665
Retail Agreements	'	'
Finite Lived and Indefinite Lived Intangible Assets	'	'
Finite-Lived Intangible Asset, Useful Life	'30 years 3 months 18 days	'
Finite-Lived Intangible Assets, Gross	31,000	31,000
Finite-Lived Intangible Assets, Accumulated Amortization	-7,828	-7,301
Finite-Lived Intangible Assets, Carrying Amount	23,172	23,699
Franchise Agreements	'	'
Finite Lived and Indefinite Lived Intangible Assets	'	'
Finite-Lived Intangible Asset, Useful Life	'25 years	'
Finite-Lived Intangible Assets, Gross	70,000	70,000
Finite-Lived Intangible Assets, Accumulated Amortization	-20,417	-19,017
Finite-Lived Intangible Assets, Carrying Amount	49,583	50,983
Manufacturing Agreements	'	'
Finite Lived and Indefinite Lived Intangible Assets	'	'
Finite-Lived Intangible Asset, Useful Life	'25 years	'
Finite-Lived Intangible Assets, Gross	70,000	70,000
Finite-Lived Intangible Assets, Accumulated Amortization	-20,417	-19,017
Finite-Lived Intangible Assets, Carrying Amount	49,583	50,983
Other Intangibles	'	'
Finite Lived and Indefinite Lived Intangible Assets	'	'
Finite-Lived Intangible Asset, Useful Life	'8 years 1 month 6 days	'
Finite-Lived Intangible Assets, Gross	21,429	20,327
Finite-Lived Intangible Assets, Accumulated Amortization	-5,855	-3,995
Finite-Lived Intangible Assets, Carrying Amount	15,574	16,332
Franchise Rights	'	'
Finite Lived and Indefinite Lived Intangible Assets	'	'
Finite-Lived Intangible Asset, Useful Life	'3 years	'
Finite-Lived Intangible Assets, Gross	5,978	5,463
Finite-Lived Intangible Assets, Accumulated Amortization	-4,942	-4,686
Finite-Lived Intangible Assets, Carrying Amount	1,036	777
Brands - Retail	'	'
Finite Lived and Indefinite Lived Intangible Assets	'	'
Balance at beginning of the period (in usd)	'	500,000
Balance at the end of the period (unaudiited) (in usd)	500,000	500,000
Brands - Franchise	'	'
Finite Lived and Indefinite Lived Intangible Assets	'	'
Balance at beginning of the period (in usd)	'	220,000
Balance at the end of the period (unaudiited) (in usd)	$220,000	$220,000

GOODWILL_AND_INTANGIBLE_ASSETS6

GOODWILL AND INTANGIBLE ASSETS, NET (Details 5) (USD $)	Jun. 30, 2014
In Thousands, unless otherwise specified
Goodwill and Intangible Assets Disclosure [Abstract]	'
2014	$5,483
2015	10,756
2016	9,870
2017	7,784
2018	7,700
Thereafter	97,355
Total	$138,948

LONGTERM_DEBT_INTEREST_EXPENSE2

LONG-TERM DEBT / INTEREST EXPENSE (Details) (USD $)

3 Months Ended

6 Months Ended

6 Months Ended

12 Months Ended

6 Months Ended

12 Months Ended

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2014

Jun. 30, 2013

Dec. 31, 2013

Dec. 31, 2013

Jun. 30, 2014

Dec. 31, 2013

Jun. 30, 2014

Dec. 31, 2013

Jun. 30, 2014

Dec. 31, 2013

Term Loan Facility

Term Loan Facility

Term Loan Facility

Term Loan Facility

Revolving Credit Facility

Revolving Credit Facility

Revolving Credit Facility

Revolving Credit Facility

Letter Of Credit

Letter Of Credit

Maximum

Maximum

Maximum

Long-term Debt

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Maximum borrowing capacity

'

'

'

'

'

'

$1,400,000,000

'

'

'

'

$80,000,000

'

'

Line of Credit Facility, Potential Borrowing Capacity Increase

'

'

'

'

'

'

'

252,500,000

'

'

'

'

'

'

Line of Credit Facility, Borrowing Capacity Increase Limit

'

'

'

'

'

'

'

'

'

'

130,000,000

'

'

'

Interest expense, net

11,675,000

11,101,000

23,206,000

22,116,000

23,200,000

22,100,000

'

'

'

'

'

'

'

'

Interest rate (as a percent)

'

'

'

'

3.25%

'

3.25%

'

'

'

'

'

'

'

Revolving Credit Facility pledged to secure letters of credit

'

'

'

'

'

'

'

'

'

'

'

'

$1,100,000

$1,100,000

Commitment fee respect of unutilized revolving loan commitments (as a percent)

'

'

'

'

'

'

'

'

0.50%

0.50%

'

'

'

'

Fee for letters of credit to lenders (as a percent)

'

'

'

'

'

'

'

'

'

'

'

'

2.50%

2.50%

LONGTERM_DEBT_INTEREST_EXPENSE3

LONG-TERM DEBT / INTEREST EXPENSE (Details 2) (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Debt Instrument	'	'
Total debt	$1,344,438	$1,347,099
Less: current maturities	-4,825	-5,443
Long-term debt	1,339,613	1,341,656
Senior Credit Facility	'	'
Debt Instrument	'	'
Total debt	1,344,069	1,345,987
Other	'	'
Debt Instrument	'	'
Total debt	$369	$1,112

FINANCIAL_INSTRUMENTS_Details

FINANCIAL INSTRUMENTS (Details) (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Carrying Amount	'	'
Actual and estimated fair values of the financial instruments	'	'
Cash and cash equivalents	$118,545	$226,217
Receivables, net	142,864	144,833
Franchise notes receivable, net	15,257	10,163
Accounts payable	148,958	135,164
Long-term debt (including current portion)	1,344,438	1,347,099
Fair Value	'	'
Actual and estimated fair values of the financial instruments	'	'
Cash and cash equivalents	118,545	226,217
Receivables, net	142,864	144,833
Franchise notes receivable, net	15,257	10,163
Accounts payable	148,958	135,164
Long-term debt (including current portion)	$1,327,632	$1,343,732

COMMITMENTS_AND_CONTINGENCIES_

COMMITMENTS AND CONTINGENCIES (Details) (USD $)

6 Months Ended

0 Months Ended

1 Months Ended

6 Months Ended

6 Months Ended

Jun. 30, 2014

Jun. 30, 2014

Dec. 14, 2011

Nov. 04, 2008

Jun. 30, 2013

Jun. 30, 2014

Jan. 07, 2013

Feb. 29, 2012

Jun. 29, 2010

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2014

Environmental Issue

California Wage And Break Claims

California Wage And Break Claims

California Wage And Break Claims

California Wage And Break Claims

California Wage And Break Claims

California Wage And Break Claims

Fair Labor Standards Act

Product Liability

Product Liability

Product Liability

count

plaintiff

plaintiff

plaintiff

claim

action

count

Hydroxycut Claims

DMAA Claims

claim

report

lawsuit

product

claim

lawsuit

action

claim

action

Commitments and contingencies

'

'

'

'

'

'

'

'

'

'

'

'

Deductible/retention per claim out of total product liability insurance

'

'

'

'

'

'

'

'

'

$4,000,000

'

'

Aggregate cap on retained loss for deductible/retention per claim out of total product liability insurance

'

'

'

'

'

'

'

'

'

10,000,000

'

'

Number of reports of liver injuries

'

'

'

'

'

'

'

'

'

'

23

'

Number of Hydroxycut-branded products recalled

'

'

'

'

'

'

'

'

'

'

14

'

Number of pending lawsuits in which company is named

'

'

'

'

'

86

'

'

'

'

76

20

Number of individual, largely personal injury claims pending

'

'

'

'

'

'

'

'

'

'

70

17

Number of putative class action cases pending against the company

'

'

'

'

'

'

'

'

'

'

6

3

Number of plaintiffs who filed individual claims against the company

'

'

'

98

'

'

'

'

'

'

'

'

Number of plaintiffs whose claim trial conducted

'

'

'

'

7

'

'

'

'

'

'

'

Number of claims against which the order is entered in favor of the entity

'

'

'

'

1

'

'

'

'

'

'

'

Number of plaintiffs whose claims have been resolved

'

'

'

'

'

5

'

'

'

'

'

'

Period within which plaintiffs can amend the complaint

'

'

'30 days

'

'

'

'

'

'

'

'

'

Loss Contingency, Number of State And Federal Wage Claims

'

'

'

'

'

'

1

'

'

'

'

'

Accrued contingent liability

'

'

'

'

'

0

'

'

'

'

'

'

Loss Contingency, Number of Counts in Complaint

'

'

'

'

'

'

'

'

2

'

'

'

Loss Contingency, Number of Causes of Action

'

'

'

'

'

'

'

8

'

'

'

'

Loss Contingency, Count Dismissed by Court

'

'

6

'

'

'

'

'

'

'

'

'

Amount of future purchase commitments

4,900,000

'

'

'

'

'

'

'

'

'

'

'

Cost of remediation

'

$0

'

'

'

'

'

'

'

'

'

'

STOCKBASED_COMPENSATION_PLANS_1

STOCK-BASED COMPENSATION PLANS (Details) (USD $)	6 Months Ended
In Millions, except Share data, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013
	plan
Stock-based compensation plans	'	'
Number of stock-based employee compensation plans	2	'
Non-cash stock-based compensation expense	$3.40	$3.90
Total unrecognized compensation cost related to non-vested stock awards	17.8	'
Weighted average period over which compensation cost is expected to be recognized	'1 year 6 months 3 days	'
Total intrinsic value of awards exercised	4.6	18.7
Total amount of cash received from the exercise of options	1.9	6.3
Tax benefit associated with the exercise of awards	1.7	7
Tax benefit associated with the exercise of awards recorded to paid-in-capital	1.2	6.3
Minimum	'	'
Stock-based compensation plans	'	'
Vesting period	'4 years	'
Expiration period	'7 years	'
Maximum	'	'
Stock-based compensation plans	'	'
Vesting period	'5 years	'
Expiration period	'10 years	'
Stock Option	'	'
Stock-based compensation plans	'	'
Options, Granted (in shares)	0	'
Weighted average date fair value per share of options granted (in dollars per share)	'	$14.01
Fair value of options vested	$1.60	$2
Stock Option | Minimum	'	'
Stock-based compensation plans	'	'
Vesting period	'4 years	'
Expiration term	'7 years	'
Stock Option | Maximum	'	'
Stock-based compensation plans	'	'
Vesting period	'5 years	'
Expiration term	'10 years	'
2011 Stock Plan	'	'
Stock-based compensation plans	'	'
Number of shares authorized for issuance	8,500,000	'
Number of shares reserved for every share granted that are Full Share Awards	1.8	'
Number of shares available for grant for every share forfeited that are Full Share Awards	1.8	'
2011 Stock Plan | Performance Vesting Restricted Stock Units	'	'
Stock-based compensation plans	'	'
Granted (in shares)	130,798	'
2011 Stock Plan | Performance Vesting Restricted Stock Units | Minimum	'	'
Stock-based compensation plans	'	'
Vesting Rights Percentage	0.00%	'
2011 Stock Plan | Performance Vesting Restricted Stock Units | Maximum	'	'
Stock-based compensation plans	'	'
Vesting Rights Percentage	200.00%	'
2011 Stock Plan | Time Vesting Restricted Stock Units	'	'
Stock-based compensation plans	'	'
Vesting period	'3 years	'
Granted (in shares)	151,412	'
2007 Stock Plan	'	'
Stock-based compensation plans	'	'
Granted (in shares)	0	'

STOCKBASED_COMPENSATION_PLANS_2

STOCK-BASED COMPENSATION PLANS (Details 2) (Stock Option, USD $)	6 Months Ended
In Thousands, except Share data, unless otherwise specified	Jun. 30, 2014
Stock Option	'
Total Options	'
Outstanding, beginning of period (in shares)	1,887,154
Exercised (in shares)	-108,024
Forfeited (in shares)	-40,814
Outstanding, ending of period (in shares)	1,738,316
Exercisable at the end of the period (in shares)	743,785
Weighted Average Exercise Price	'
Outstanding, beginning of period (in dollars per share)	$24.14
Exercised (in dollars per share)	$17.04
Forfeited (in dollars per share)	$31.20
Outstanding, end of period (in dollars per share)	$24.41
Exercisable at the end of the period (in dollars per share)	$21.32
Weighted Average Remaining Contractual Term (in years)	'
Options, Outstanding, Weighted Average Remaining Contractual Term	'5 years 1 month 6 days
Options, Exercisable, Weighted Average Remaining Contractual Term	'5 years 2 months 12 days
Aggregate Intrinsic Value	'
Outstanding at the end of the period	$16,844
Exercisable at the end of the period	$9,506

STOCKBASED_COMPENSATION_PLANS_3

STOCK-BASED COMPENSATION PLANS (Details 3) (2011 Stock Plan, Restricted Stock, USD $)	6 Months Ended
	Jun. 30, 2014
2011 Stock Plan | Restricted Stock	'
Restricted Stock	'
Outstanding, beginning of period (in shares)	114,981
Granted (in shares)	10,404
Vested ( in shares)	-20,436
Forfeited (in shares)	-4,718
Outstanding, end of period (in shares)	100,231
Weighted Average Grant-Date Fair Value	'
Outstanding, beginning of period (in dollars per share)	$25.16
Granted (in dollars per share)	$36.52
Vested ( in dollars per share)	$32.40
Forfeited (in dollars per share)	$29.36
Outstanding, end of period (in dollars per share)	$24.67

STOCKBASED_COMPENSATION_PLANS_4

STOCK-BASED COMPENSATION PLANS (Details 4) (2011 Stock Plan, USD $)	6 Months Ended
	Jun. 30, 2014
Time Vesting Restricted Stock Units	'
Time Vesting and Performance Vesting Restricted Stock Units	'
Outstanding, beginning of period (in shares)	141,298
Granted (in shares)	151,412
Vested ( in shares)	-1,014
Forfeited (in shares)	-3,778
Outstanding, end of period (in shares)	287,918
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]	'
Outstanding, beginning of period (in dollars per share)	$40.81
Granted (in dollars per share)	$43.99
Vested ( in dollars per share)	$45.57
Forfeited (in dollars per share)	$35.72
Outstanding, end of period (in dollars per share)	$42.53
Performance Vesting Restricted Stock Units	'
Time Vesting and Performance Vesting Restricted Stock Units	'
Outstanding, beginning of period (in shares)	55,366
Granted (in shares)	130,798
Vested ( in shares)	0
Forfeited (in shares)	-2,074
Outstanding, end of period (in shares)	184,090
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]	'
Outstanding, beginning of period (in dollars per share)	$45.94
Granted (in dollars per share)	$44.62
Vested ( in dollars per share)	$0
Forfeited (in dollars per share)	$42.19
Outstanding, end of period (in dollars per share)	$45.04

SEGMENTS_Details

SEGMENTS (Details) (USD $)	3 Months Ended		6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
			segment
Segment Reporting [Abstract]	'	'	'	'
Number of reportable segments	'	'	3	'
Revenue:	'	'	'	'
Total revenue	$675,216	$676,276	$1,352,492	$1,340,966
Operating income:	'	'	'	'
Operating income	121,051	123,671	242,306	248,191
Interest expense, net	11,675	11,101	23,206	22,116
Income before income taxes	109,376	112,570	219,100	226,075
Operating Segment	'	'	'	'
Revenue:	'	'	'	'
Total revenue	739,074	743,822	1,485,108	1,473,983
Operating Segment | Intersegment Revenues	'	'	'	'
Revenue:	'	'	'	'
Total revenue	-63,858	-67,546	-132,616	-133,017
Operating Segment | Retail	'	'	'	'
Revenue:	'	'	'	'
Total revenue	505,508	502,490	1,014,506	995,957
Operating income:	'	'	'	'
Operating income	94,425	100,344	188,545	198,927
Operating Segment | Franchise	'	'	'	'
Revenue:	'	'	'	'
Total revenue	110,142	110,560	216,476	218,446
Operating income:	'	'	'	'
Operating income	41,116	36,650	81,313	75,075
Operating Segment | Manufacturing/ Wholesale	'	'	'	'
Revenue:	'	'	'	'
Total revenue	123,424	130,772	254,126	259,580
Operating income:	'	'	'	'
Operating income	22,932	25,507	46,443	48,434
Operating Segment | Manufacturing/ Wholesale | Intersegment Revenues	'	'	'	'
Revenue:	'	'	'	'
Total revenue	63,858	67,546	132,616	133,017
Operating Segment | Manufacturing/ Wholesale | Third Party	'	'	'	'
Revenue:	'	'	'	'
Total revenue	59,566	63,226	121,510	126,563
Corporate, Non-Segment	'	'	'	'
Operating income:	'	'	'	'
Warehousing and distribution costs	-17,047	-16,869	-32,981	-33,224
Corporate costs	-20,375	-21,961	-41,014	-41,021
Subtotal unallocated corporate and other costs	($37,422)	($38,830)	($73,995)	($74,245)

INCOME_TAXES_Details

INCOME TAXES (Details) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013	Dec. 31, 2013
Income Tax Disclosure [Abstract]	'	'	'	'	'
Income tax expense	$39,489,000	$40,882,000	$79,310,000	$81,744,000	'
Effective income tax rate (as a percent)	'	'	36.20%	36.20%	'
Unrecognized tax benefits	11,200,000	'	11,200,000	'	10,800,000
Unrecognized tax benefits that would affect the effective tax rate	11,200,000	'	11,200,000	'	'
Interest and penalties accrued related to unrecognized tax benefits	$4,200,000	'	$4,200,000	'	$4,200,000

SUBSEQUENT_EVENTS_Details

SUBSEQUENT EVENTS (Details) (Scenario, Forecast [Member], USD $)	0 Months Ended
	Jul. 24, 2014
Scenario, Forecast [Member]	'
Subsequent events	'
Dividends declared per share (in dollars per share)	$0.16